RCM
MRNA icon

RB Capital Management’s Moderna MRNA Stock Holding History

RB Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,872
Closed -$288K – 182
2023
Q1 		$288K Sell
1,872
-27
-1% -$4.45K 0.09% 149
2022
Q4 		$341K Sell
1,899
-300
-14% -$49.1K 0.12% 128
2022
Q3 		$260K Buy
2,199
+92
+4% +$14K 0.1% 146
2022
Q2 		$301K Sell
2,107
-160
-7% -$22.9K 0.11% 135
2022
Q1 		$391K Buy
2,267
+158
+7% +$26.6K 0.13% 126
2021
Q4 		$536K Buy
2,109
+144
+7% +$42.1K 0.17% 102
2021
Q3 		$756K Buy
1,965
+47
+2% +$17.3K 0.28% 77
2021
Q2 		$451K Buy
+1,918
New +$343K 0.17% 110

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RB Capital Management's MRNA Position: Q2 2023 in Review

RB Capital Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,872 shares — an estimated $288K sold.

RB Capital Management first reported a position in MRNA in Q2 2021 and held it in 8 quarters. The position peaked at $756K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • RB Capital Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • RB Capital Management sold 1,872 Moderna shares in Q2 2023, an estimated $288K.
  • RB Capital Management first reported a position in Moderna in Q2 2021 and held it in 8 quarters.
  • RB Capital Management's Moderna position peaked at $756K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on RB Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.